Washington H Soul Pattinson & Company Ltd (SOL)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 46.20 |
|---|---|
| 52-week range | 34.78 – 49.43 |
| Return, 1 month / 3 months | +2.9% / +2.7% |
| Return, 1 year / 3 years | +25.2% / +48.2% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 18.9% |
| Worst drawdown (1 year) | -7.9% |
| Average daily value traded | 24.77M AUD |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Washington H Soul Pattinson and Company is an Australian investment house based in Sydney. It began as a pharmacy business and still operates a chain of chemists, but most of its activity now centres on managing a diversified portfolio of investments. These holdings span resources, telecommunications, building materials and other industries, and the company takes long-term stakes in businesses rather than trading actively. Its shareholders are investors seeking exposure to a broad mix of Australian assets.
On this site Washington H Soul Pattinson & Company Ltd appears as a stock on the Australian Securities Exchange (Australia), code SOL, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Washington H Soul Pattinson & Company Ltd (SOL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 46.20 on 23 October 2026.
Its price-based Market X-Ray is 86 out of 100 (a strong price profile), ranking 19 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.2% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.0% | ||
| From 52-week high | -4.4% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | 10.8% | ||
| 12-month return, skipping the last month | 21.7% | ||
| Stability (higher is calmer) | 97 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -7.9% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 24.77M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +2.9% |
| 3 months | +2.7% |
| 6 months | +10.7% |
| 1 year | +25.2% |
| 3 years | +48.2% |
| 5 years | +58.0% |
Signals
| 50-day / 200-day average | 44.77 / 41.99 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Oct 2026 | AUD 0.6300 |
| 20 Apr 2026 | AUD 0.4800 |
| 21 Aug 2025 | AUD 0.5900 |
| 15 Apr 2025 | AUD 0.4400 |
| 15 Oct 2024 | AUD 0.5500 |
| 17 Apr 2024 | AUD 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.